In contrast, while antibody therapy only modestly increased IFN-γ-producing CD4+ T cells in the tumor, tritherapy significantly increased IFN-γ+, TNF-α + and IFN-γ + TNF-α + CD4+ T cells compared to all other treatments (Fig. 4d-e). The gene discussed is CD4; the disease is neoplasm.